Home › NDC Lookup › RxCUI directory › RxCUI 2675565

Riluzole 5 MG/ML Oral Suspension [Teglutik] — RxCUI 2675565

RxNorm drug concept · Semantic branded drug
RxCUI 2675565 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2675565
Official nameRiluzole 5 MG/ML Oral Suspension [Teglutik]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTeglutik 5 MG/mL Oral Suspension; Teglutik 50 MG per 10 mL Oral Suspension
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Riluzole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Riluzole doesn't cure ALS, and it won't reverse the damage already done. It's approved to treat the disease, but honestly, scientists still don't fully understand the exact way it...
  • What exactly does riluzole do for ALS — does it cure it?
  • Food — especially a high-fat meal — can cut the amount of riluzole your body absorbs quite significantly. To get the most from each dose, take it at least 1 hour before eating or 2...
  • Why do I have to take it on an empty stomach? Can I take it with a light snack?
📖 Read our full Riluzole guide →

🕸️ Concept Web — How Riluzole 5 MG/ML Oral Suspension [Teglutik] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Riluzole 5 MG/ML Oral Suspension [Teglutik] RxCUI 2675565

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Riluzole 35623
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Teglutik 2675560
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Riluzole Oral Suspension 2058146
    • Riluzole Oral Liquid Product 2058145
    • Riluzole Oral Product 1165471
    • Riluzole Oral Suspension [Teglutik] 2675564
    • Teglutik Oral Liquid Product 2675563
    • Teglutik Oral Product 2675562
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Riluzole 5 MG/ML Oral Suspension SCD · 2058147
  • Riluzole 5 MG/ML SCDC · 2058144
  • Riluzole Oral Suspension SCDF · 2058146
  • Riluzole Oral Liquid Product SCDG · 2058145
  • Riluzole Oral Product SCDG · 1165471

Brand-Name Concepts

  • Riluzole 5 MG/ML [Teglutik] SBDC · 2675561
  • Riluzole Oral Suspension [Teglutik] SBDF · 2675564
  • Teglutik Oral Liquid Product SBDG · 2675563
  • Teglutik Oral Product SBDG · 2675562
  • Teglutik BN · 2675560

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2675565 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70726-0304-01 300 mL in 1 BOTTLE, PLASTIC (70726-0304-1) Teglutik EDW PHARMA, INC 2024-01-19
70726-0305-01 300 mL in 1 BOTTLE, PLASTIC (70726-0305-1) Teglutik EDW PHARMA 2024-03-08
70726-0306-01 300 mL in 1 BOTTLE, PLASTIC (70726-0306-1) Teglutik EDW PHARMA 2024-06-10
Observed labelers: EDW PHARMA (2) · EDW PHARMA, INC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.